Literature DB >> 2922280

Activation of interferon-regulated, dsRNA-dependent enzymes by human immunodeficiency virus-1 leader RNA.

D N SenGupta1, R H Silverman.   

Abstract

Human immunodeficiency virus-1 (HIV-1) leader RNA, which contains double-stranded regions due to inverted repeats, was shown to activate the dsRNA-dependent enzymes associated with the interferon system. HIV-1 leader RNA produced in vitro using SP6 RNA polymerase was characterized using probes for antisense and sense-strand RNA. The RNA preparation was free from significant levels of antisense RNA. HIV-1 leader RNA was shown to activate dsRNA-dependent protein kinase in a cell-free system from interferon-treated HeLa cells. Affinity resins, consisting of HIV-1 leader RNA covalently attached to cellulose, immobilized and activated dsRNA-dependent protein kinase and 2-5A-synthetase. HIV-1 leader RNA, therefore, may be a contributing factor in the mechanism by which interferon inhibits HIV replication.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2922280      PMCID: PMC331716          DOI: 10.1093/nar/17.3.969

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  38 in total

1.  Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus.

Authors:  M A Muesing; D H Smith; C D Cabradilla; C V Benton; L A Lasky; D J Capon
Journal:  Nature       Date:  1985 Feb 7-13       Impact factor: 49.962

2.  Inhibition of mRNA binding to ribosomes by localized activation of dsRNA-dependent protein kinase.

Authors:  A De Benedetti; C Baglioni
Journal:  Nature       Date:  1984 Sep 6-11       Impact factor: 49.962

3.  Recombinant human interferon alfa-A suppresses HTLV-III replication in vitro.

Authors:  D D Ho; K L Hartshorn; T R Rota; C A Andrews; J C Kaplan; R T Schooley; M S Hirsch
Journal:  Lancet       Date:  1985-03-16       Impact factor: 79.321

4.  Recombinant alpha-2 interferon therapy for Kaposi's sarcoma associated with the acquired immunodeficiency syndrome.

Authors:  J E Groopman; M S Gottlieb; J Goodman; R T Mitsuyasu; M A Conant; H Prince; J L Fahey; M Derezin; W M Weinstein; C Casavante
Journal:  Ann Intern Med       Date:  1984-05       Impact factor: 25.391

5.  Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter.

Authors:  D A Melton; P A Krieg; M R Rebagliati; T Maniatis; K Zinn; M R Green
Journal:  Nucleic Acids Res       Date:  1984-09-25       Impact factor: 16.971

6.  Resistance of vaccinia virus to interferon is related to an interference phenomenon between the virus and the interferon system.

Authors:  E Paez; M Esteban
Journal:  Virology       Date:  1984-04-15       Impact factor: 3.616

7.  Preliminary observations on the effect of recombinant leukocyte A interferon in homosexual men with Kaposi's sarcoma.

Authors:  S E Krown; F X Real; S Cunningham-Rundles; P L Myskowski; B Koziner; S Fein; A Mittelman; H F Oettgen; B Safai
Journal:  N Engl J Med       Date:  1983-05-05       Impact factor: 91.245

8.  Interferon-mediated, double-stranded RNA-dependent protein kinase is inhibited in extracts from vaccinia virus-infected cells.

Authors:  A P Rice; I M Kerr
Journal:  J Virol       Date:  1984-04       Impact factor: 5.103

9.  An improved method for purifying 2',5'-oligoadenylate synthetases.

Authors:  J A Wells; E A Swyryd; G R Stark
Journal:  J Biol Chem       Date:  1984-01-25       Impact factor: 5.157

10.  Mutational analysis of the 5' non-coding region of human immunodeficiency virus type 1: effects of secondary structure on translation.

Authors:  N T Parkin; E A Cohen; A Darveau; C Rosen; W Haseltine; N Sonenberg
Journal:  EMBO J       Date:  1988-09       Impact factor: 11.598

View more
  39 in total

1.  Analysis of PKR activation using analytical ultracentrifugation.

Authors:  James L Cole
Journal:  Macromol Biosci       Date:  2010-07-07       Impact factor: 4.979

2.  Variable inhibition of cell-free translation by HIV-1 transcript leader sequences.

Authors:  A P Geballe; M K Gray
Journal:  Nucleic Acids Res       Date:  1992-08-25       Impact factor: 16.971

3.  Functional expression and RNA binding analysis of the interferon-induced, double-stranded RNA-activated, 68,000-Mr protein kinase in a cell-free system.

Authors:  M G Katze; M Wambach; M L Wong; M Garfinkel; E Meurs; K Chong; B R Williams; A G Hovanessian; G N Barber
Journal:  Mol Cell Biol       Date:  1991-11       Impact factor: 4.272

4.  Structural requirements for trans activation of human immunodeficiency virus type 1 long terminal repeat-directed gene expression by tat: importance of base pairing, loop sequence, and bulges in the tat-responsive sequence.

Authors:  S Roy; N T Parkin; C Rosen; J Itovitch; N Sonenberg
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

Review 5.  Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response.

Authors:  Robert H Silverman
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

6.  Degradation of the interferon-induced 68,000-M(r) protein kinase by poliovirus requires RNA.

Authors:  T L Black; G N Barber; M G Katze
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

7.  Characterization and mapping of the double-stranded regions involved in activation of PKR within a cellular RNA from 3T3-F442A cells.

Authors:  R A Petryshyn; A G Ferrenz; J Li
Journal:  Nucleic Acids Res       Date:  1997-07-01       Impact factor: 16.971

8.  Regulation of the double-stranded RNA-dependent protein kinase PKR by RNAs encoded by a repeated sequence in the Epstein-Barr virus genome.

Authors:  A Elia; K G Laing; A Schofield; V J Tilleray; M J Clemens
Journal:  Nucleic Acids Res       Date:  1996-11-15       Impact factor: 16.971

9.  Identification of cellular proteins that bind to the human immunodeficiency virus type 1 trans-activation-responsive TAR element RNA.

Authors:  A Gatignol; A Kumar; A Rabson; K T Jeang
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

10.  RNA dimerization promotes PKR dimerization and activation.

Authors:  Laurie A Heinicke; C Jason Wong; Jeffrey Lary; Subba Rao Nallagatla; Amy Diegelman-Parente; Xiaofeng Zheng; James L Cole; Philip C Bevilacqua
Journal:  J Mol Biol       Date:  2009-05-13       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.